Lee Ainslie - Maverick Capital
Holding/activity history for Viridian Therapeutics Inc (VRDN)
← All VRDN superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | 0 | 0.00 | Sell 100.00% | 0.64 | $20.69–34.04 · VW $27.97i | SEC | |
| 2025 Q3 | 2,212,701 | 0.64 | Reduce 1.96% | <0.01 | $13.84–21.72 · VW $18.37i | $47,750,088 | SEC |
| 2025 Q2 | 2,257,010 | 0.48 | Add 9.50% | 0.04 | $9.90–16.29 · VW $13.40i | $31,553,000 | SEC |
| 2025 Q1 | 2,061,274 | 0.50 | Add 0.36% | <0.01 | $13.23–21.58 · VW $17.18i | $27,785,974 | SEC |
| 2024 Q4 | 2,053,906 | 0.71 | Add 2.84% | 0.02 | $17.06–27.20 · VW $21.49i | $39,373,378 | SEC |
| 2024 Q3 | 1,997,153 | 0.89 | Reduce 39.63% | 0.32 | $11.85–23.80 · VW $18.08i | $45,435,231 | SEC |
| 2024 Q2 | 3,307,945 | 0.82 | Add 22.86% | 0.15 | $11.40–17.69 · VW $13.38i | $43,036,364 | SEC |
| 2024 Q1 | 2,692,414 | 0.88 | Add 15.76% | 0.12 | $16.16–24.18 · VW $19.21i | $47,144,169 | SEC |
| 2023 Q4 | 2,325,841 | 1.01 | Buy | 1.01 | $10.93–23.53 · VW $16.36i | $50,656,817 | SEC |